Morgan Stanley’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Sell |
1,209,803
-760,167
| -39% | -$1.48M | ﹤0.01% | 4593 |
|
|
2025
Q1 | $3.47M | Buy |
1,969,970
+897,134
| +84% | +$1.58M | ﹤0.01% | 4221 |
|
|
2024
Q4 | $2.85M | Sell |
1,072,836
-110,035
| -9% | -$293K | ﹤0.01% | 4440 |
|
|
2024
Q3 | $2.71M | Buy |
1,182,871
+144,185
| +14% | +$330K | ﹤0.01% | 4440 |
|
|
2024
Q2 | $3.03M | Sell |
1,038,686
-142,915
| -12% | -$417K | ﹤0.01% | 4277 |
|
|
2024
Q1 | $4.3M | Sell |
1,181,601
-423,487
| -26% | -$1.54M | ﹤0.01% | 4024 |
|
|
2023
Q4 | $2.42M | Buy |
1,605,088
+1,160,590
| +261% | +$1.75M | ﹤0.01% | 4814 |
|
|
2023
Q3 | $596K | Sell |
444,498
-169,736
| -28% | -$227K | ﹤0.01% | 5088 |
|
|
2023
Q2 | $1.11M | Buy |
614,234
+165,593
| +37% | +$298K | ﹤0.01% | 4773 |
|
|
2023
Q1 | $745K | Buy |
448,641
+13,747
| +3% | +$22.8K | ﹤0.01% | 5032 |
|
|
2022
Q4 | $835K | Buy |
434,894
+234,120
| +117% | +$450K | ﹤0.01% | 4964 |
|
|
2022
Q3 | $449K | Buy |
200,774
+18,398
| +10% | +$41.1K | ﹤0.01% | 5319 |
|
|
2022
Q2 | $591K | Buy |
182,376
+62,824
| +53% | +$204K | ﹤0.01% | 5332 |
|
|
2022
Q1 | $629K | Sell |
119,552
-47,716
| -29% | -$251K | ﹤0.01% | 5273 |
|
|
2021
Q4 | $1.42M | Buy |
167,268
+90,409
| +118% | +$768K | ﹤0.01% | 4833 |
|
|
2021
Q3 | $764K | Buy |
76,859
+24,419
| +47% | +$243K | ﹤0.01% | 5230 |
|
|
2021
Q2 | $488K | Buy |
52,440
+1,890
| +4% | +$17.6K | ﹤0.01% | 5531 |
|
|
2021
Q1 | $528K | Buy |
50,550
+50,458
| +54,846% | +$527K | ﹤0.01% | 5123 |
|
|
2020
Q4 | $1K | Buy |
+92
| New | +$1K | ﹤0.01% | 6954 |
|